The use of monoclonal antibodies and antibody fragments in the imaging of infectious lesions

Dedicated to Professor Sabine von Kleist on the occasion of her 60th birthday.
https://doi.org/10.1016/S0001-2998(05)80228-4Get rights and content

The advantage of immunoscintigraphy over autologous leukocyte techniques in the imaging of infection is the simplicity of its use compared with techniques that require the isolation of autologous white blood cells. The advantage over 99mTc- or 111In-labeled non-specific human immunoglobulin is the excellent targetto-background ratio, which results from an endogenous background subtraction with the whole antigranulocyte antibody (99mTc-anti-NCA-95; BW250/183) and a rapid clearance of the antibody using an antigranulocyte Fab-fragment (99mTc-anti-NCA-90; IMMU-MN3). The whole antibody is helpful for imaging of soft tissue infections, peripheral bone, and abdominal infections. Problems may arise occasionally in regions with normal bone marrow that are caused by human antimouse antibody (HAMA) formation. An infection or the entire extent of inflammation can be proven or excluded only at 24 hours postinjection. In contrast, antigranulocyte Fab'-fragment may have its advantage in an earlier localization of infectious lesions (1 hour) owing to its smaller molecular size and its lower affinity for its epitope. This may be promising in the detection of spinal infections and in infections in regions with the presence of normal bone marrow. Also advantageous is the negligible HAMA response rate. Problems may arise in abdominal infections because of an intestinal excretion of activity as early as 4 hours postinjection in some cases but more usually at 24 hours.

References (65)

  • ThakurML et al.

    Indium-111 labeled autologous leucocytes in man

    J Nucl Med

    (1977)
  • Rojas-BurkeJ

    Health officials reactions to infection mishaps

    J Nucl Med

    (1992)
  • von KleistS et al.

    Identification of an antigen from normal human tissue that crossreacts with the carcinoembryonic antigen

  • BurtinP et al.

    Non-specific crossreactive antigen as a marker for human polymorphs, macrophages and monocytes

    Nature

    (1975)
  • LocherJTh et al.

    Imaging of inflammatory and infectious lesions after injection of radioiodinated monoclonal antigranulocyte antibodies

    Nucl Med Comm

    (1986)
  • JosephK et al.

    In-vivo-Markierung von Granulozyten mit Tc-99m-markierten monoklonalen Antikörpern: Erste klinische Ergebnisse

    NucCompact

    (1987)
  • BeckerW et al.

    Comparison of Tc-99m-antigranulocyte (NCA-95) Fab'-fragments and scintigraphy with In-111 oxin/Tc-99m-HMPAO-labelled leukocytes in infectious diseases

    J Nucl Med

    (1992)
  • ThakurML et al.

    Monoclonal antibodies as agents for selective radiolabeling of human neutrophils

    J Nucl Med

    (1988)
  • BucheggerF et al.

    Monoclonal antibodies identify a CEA crossreacting antigen of 95kD(NCA-95) distinct in antigenicity and tissue distribution from the previously described NCA of 55 kD

    Int J Cancer

    (1984)
  • NoworolskaA et al.

    Expression of nonspecific cross-reacting antigen species in myeloid leukemia patients and healthy subjects

    Blut

    (1989)
  • BerlingB et al.

    Cloning of a carcinoembryonic antigen gene family member expressed in leukocytes of chronic myeloid leukemia patients and bone marrow

    Cancer Res

    (1990)
  • WattSM et al.

    CD66 identifies a neutrophil-specific epitope within the hematopoietic system that is expressed by members of the carcinoembryonic antigen family of adhesion molecules

    Blood

    (1991)
  • OikawaS et al.

    Cell adhesion activity of non-specific cross-reacting antigen (NCA) and carcinoembryonic antigen (CEA) expressed on CHO cell surface: homophilic and heterophilic adhesion

    Biochem Biophys Res Commun

    (1989)
  • BenchimolS et al.

    Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule

    Cell

    (1989)
  • LeuschHG et al.

    Escherichia coli of human origin binds to carcinoembryonic antigen (CEA) and non-specific cross-reacting antigen (NCA)

    FEBS Lett

    (1990)
  • SolterD et al.

    Monoclonal antibodies defined a stage specific mouse in ionic antigen (SSEA-1)

  • BossletK et al.

    Generation and functional characteristics of the granulocyte selective monoclonal antibody BW250/183

    Nukl Med

    (1989)
  • JosephK et al.

    In vivo labelling of granulocytes with Tc-99m-anti-NCA monoclonal antibodies for imaging inflammation

    Eur J Nucl Med

    (1988)
  • AndresRY et al.

    Immunoscintigraphic localization of inflammatory lesions: concept radiolabelling and in-vitro-testing of a granulocyte specific antibody

    Eur J Nucl Med

    (1988)
  • MaschekW et al.

    Kinetic und immunozytochemische Färbung monoklonaler Tc-99m-markierter Anti-CEA-Antikörper gegen Granulozyten nach intravenöser Applikation

    Nukl Med

    (1990)
  • SchubigerPA et al.

    Assessment of the binding properties of Granuloszint

    Eur J Nucl Med

    (1989)
  • SteinsträsserA et al.

    Bindung des monoklonalen Antikörpers BW250/183 an menschliche Granulozyten

    Nukl Med

    (1992)
  • Becker W, Bair J, Repp R, et al: Disclosure of soft tissue infections and osteomyelitis with a new technetium labelled...
  • WattSM et al.

    CD66 identifies a neutrophil specific epitope within the hematopoetic system that is expressed by members of the carcinoembryonic antigen family of adhesion molecules

    Blood

    (1991)
  • SchwarzA et al.

    A novel approach to Tc-99m-labelled monoclonal antibodies

    J Nucl Med

    (1987)
  • HansenHJ et al.

    Preclinical evaluation of an ‘instant’ Tc-99m-labelling kit for antibody imaging

    Cancer Res

    (1990)
  • Abdel-NabiH et al.

    Recurrent colorectal carcinoma detection with repeated infusions of In-111 ZCE-025 MoAb

    J Nucl Med

    (1989)
  • HaslerPH et al.

    Immunoscintigraphic localization of inflammatory lesions: Pharmacokinetics and estimated absorbed radiation dose in man

    Eur J Nucl Med

    (1988)
  • BeckerW et al.

    Kinetic data of in-vivo labeled granulocytes in humans with a murine Tc-99m-labelled monoclonal antibody

    Eur J Nucl Med

    (1989)
  • DillmanRO et al.

    Lack of radioimmunodetection and complications associated with monoclonal anticarcinoembryonic antigen antibody cross reactivity with an antigen on circulating cells

    Cancer Res

    (1984)
  • BeckerW et al.

    Kinetic of In-111-oxin labelled, Tc-99m-anti-NCA-95-MOAB in-vivo and in-vitro labelled granulocytes

  • BeckerW et al.

    In vivo viability of In-111-labelled granulocytes demonstrated in a shamdialysis model

    Br J Radiol

    (1989)
  • Cited by (0)

    View full text